{"date":"2025-11-24","count":10,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6696-2025-11-24-2119-1da7h4c","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-11-24","time":"21:19:09","subject":"代重要子公司Belite Bio (HK) Limited公告董事會決議讓與RBP4 專門技術及相關帳列資產與現金增資子公司Belite Bio (Swiss) AG","clause":"第17款","fact_date":"2025-11-24","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-11-24 21:19，「代重要子公司Belite Bio (HK) Limited公告董事會決議讓與RBP4 專門技術及相關帳列資產與現金增資子」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2025-11-24-1855-1mlw4y7","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2025-11-24","time":"18:55:02","subject":"上游原料疑涉爭議成分之說明","clause":"第53款","fact_date":"2025-11-24","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2025-11-24 18:55，「上游原料疑涉爭議成分之說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7850-2025-11-24-1835-nb50we","company_id":"7850","company":"寶泰生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-24","time":"18:35:37","subject":"本公司受邀參加統一證券2025Q4全球展望冬季投資論壇","clause":"第30款","fact_date":"2025-11-25","cite_as":"公開資訊觀測站重大訊息：寶泰生醫（7850），2025-11-24 18:35，「本公司受邀參加統一證券2025Q4全球展望冬季投資論壇」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-11-24-1814-hh6fl4","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-11-24","time":"18:14:56","subject":"本公司透過子公司投資並取得NAGH全數股權業已取得經濟部投資審議司核准(補充114/09/24公告)","clause":"第20款","fact_date":"2025-09-23","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-11-24 18:14，「本公司透過子公司投資並取得NAGH全數股權業已取得經濟部投資審議司核准(補充114/09/24公告)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-11-24-1711-18dhjk","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-11-24","time":"17:11:12","subject":"公告本公司訂定減資基準日、減資換發股票基準日及減資換發股票作業計畫等相關事宜","clause":"第11款","fact_date":"2025-11-24","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-11-24 17:11，「公告本公司訂定減資基準日、減資換發股票基準日及減資換發股票作業計畫等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1788-2025-11-24-1710-cpnzac","company_id":"1788","company":"杏昌","market":"上櫃","industry":"生技醫療","date":"2025-11-24","time":"17:10:04","subject":"公告本公司召開自辦線上法說會","clause":"第12款","fact_date":"2025-11-25","cite_as":"公開資訊觀測站重大訊息：杏昌（1788），2025-11-24 17:10，「公告本公司召開自辦線上法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-11-24-1618-1h3ceio","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-11-24","time":"16:18:09","subject":"公告本公司董事會決議買回庫藏股","clause":"第35款","fact_date":"2025-11-24","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-11-24 16:18，「公告本公司董事會決議買回庫藏股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2025-11-24-1538-1wlcvdq","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2025-11-24","time":"15:38:33","subject":"本公司於2025/11/25召開法人說明會之相關資訊","clause":"第12款","fact_date":"2025-11-25","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2025-11-24 15:38，「本公司於2025/11/25召開法人說明會之相關資訊」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-11-24-1440-hithro","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-11-24","time":"14:40:55","subject":"本公司受邀參加華南永昌綜合證券舉辦之法人說明會","clause":"第30款","fact_date":"2025-11-27","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-11-24 14:40，「本公司受邀參加華南永昌綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4133-2025-11-24-1204-m71431","company_id":"4133","company":"亞諾法","market":"上市","industry":"生技醫療","date":"2025-11-24","time":"12:04:45","subject":"本公司受邀參加凱基證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-11-27","cite_as":"公開資訊觀測站重大訊息：亞諾法（4133），2025-11-24 12:04，「本公司受邀參加凱基證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}